These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Preliminary report on antidepressant treatment of irritable bowel syndrome: comments on comparison with anxiolytic therapy. Greenbaum DS Psychopharmacol Bull; 1984; 20(4):622-8. PubMed ID: 6149598 [No Abstract] [Full Text] [Related]
5. A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder. Feighner JP; Merideth CH; Hendrickson GA J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):103-8. PubMed ID: 6130066 [TBL] [Abstract][Full Text] [Related]
6. Alprazolam and amitryptyline: a double blind comparison of anxiolytic and anti-depressant activity. Draper RJ; Daly I Ir Med J; 1983 Nov; 76(11):453-6. PubMed ID: 6139353 [No Abstract] [Full Text] [Related]
7. [Use of benzodiazepines in the treatment of depression]. Escande M; Granier F; Girard M Encephale; 1983; 9(4 Suppl 2):273B-277B. PubMed ID: 6144524 [TBL] [Abstract][Full Text] [Related]
8. Buspirone and diazepam in anxiety: a controlled study. Rickels K; Weisman K; Norstad N; Singer M; Stoltz D; Brown A; Danton J J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):81-6. PubMed ID: 6130078 [TBL] [Abstract][Full Text] [Related]
9. Multicenter trials and complementary studies of cloxazolam, a new anxiolytic drug. Fischer-Cornelssen KA Arzneimittelforschung; 1981; 31(10):1757-65. PubMed ID: 6119092 [No Abstract] [Full Text] [Related]
11. [Chronobiological similarity of the specific activity of anxiolytic and antidepressant drugs]. Arushanian EB; Beĭer EV Eksp Klin Farmakol; 2007; 70(5):52-8. PubMed ID: 18074809 [TBL] [Abstract][Full Text] [Related]
12. Open trial of buspirone in the treatment of major depressive disorder. Schweizer EE; Amsterdam J; Rickels K; Kaplan M; Droba M Psychopharmacol Bull; 1986; 22(1):183-5. PubMed ID: 2873610 [No Abstract] [Full Text] [Related]
13. A small double-blind comparison of ketazolam and diazepam in the treatment of anxiety by general practitioners in Great Britain. Davies JG; Rose AJ Br J Clin Pract; 1983 Apr; 37(4):136-9. PubMed ID: 6136293 [No Abstract] [Full Text] [Related]
14. An evaluation of once daily long acting propranolol hydrochloride (Inderal LA and Half-Inderal LA) in the treatment of anxiety. A double-blind placebo-controlled general practice study. Hudson CF Br J Clin Pract; 1988 Oct; 42(10):419-26. PubMed ID: 3076469 [No Abstract] [Full Text] [Related]
15. "Buspirone: a clinical review of a new, non-benzodiazepine anxiolytic". Uhlenhuth EH J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):109-16. PubMed ID: 6130067 [TBL] [Abstract][Full Text] [Related]
16. Is the drug effect antianxiety or antidepressant [proceedings]? Overall JE Psychopharmacol Bull; 1977 Apr; 13(2):11-2. PubMed ID: 16307 [No Abstract] [Full Text] [Related]
17. [Bromazepam versus placebo. Double-blind crossover study]. Rey A; Bovet J; Schneider PB Schweiz Rundsch Med Prax; 1984 Jan; 73(5):143-8. PubMed ID: 6142517 [No Abstract] [Full Text] [Related]
18. Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral symptoms: effects of anxiolytic and cannabinoid drugs. Hayase T BMC Neurosci; 2007 Sep; 8():76. PubMed ID: 17877812 [TBL] [Abstract][Full Text] [Related]
19. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum. Sarris J; Kavanagh DJ; Adams J; Bone K; Byrne G Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072 [TBL] [Abstract][Full Text] [Related]
20. Benzodiazepines in depressive disorders. Schatzberg AF; Cole JO Arch Gen Psychiatry; 1978 Nov; 35(11):1359-65. PubMed ID: 30428 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]